t to skin, its superb safety and tolerability with no side effects, and its compatibility with other potent skin care actives, NIA-114™ is poised to be a dominant skin care technology for years to come. In fact, NIA-114™ is so effective it has been chosen by the National Cancer Institute for further study as a possible skin cancer prevention agent.
StriVectin products are available at department store and specialty retailers nationwide, and at strivectin.com.
About The Skin Cancer Foundation
The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. For more information, visit www.SkinCancer.org.
StriVectin® is the largest independent prestige skin care company, focusing on clinical anti-aging skin care solutions. Backed by science and rigorous clinical validation, StriVectin is at the forefront of skin care technology and product innovation. Its unique dual-use repair cream StriVectin-SDTM Intensive Concentrate for Stretch Marks and Wrinkles is a best-seller around the world, and is often credited with starting the clinical cosmeceutical skin care category. StriVectin products are sold through department stores and specialty retailers in North America, Europe, the Middle East and Asia. The company maintains corporate offices in New York, NY, and Raleigh, NC, and research facilities in Tucson, AZ. For more information, visit strivectin.com Page: 1 2 Related biology technology :1
. Neuralstem Receives Notice of Patent Allowance for Spinal Cord Delivery Platform2
. CorMatrix Receives Carotid Artery Repair Indication for its CorMatrix® ECM®3
. Ventana Medical Systems, Inc. Receives First FDA 510(k) Clearance for H. pylori Antibody4
. Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology5
. JCM Receives the Approval for its Manufacturing Environmental Assessment6
. OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System7
. University of Houston receives NSF grant for high school teachers program8
. GeNO LLC Receives Federal Grant To Advance Studies of Inhaled Nitric Oxide Product for the Treatment of Chronic Pulmonary Diseases9
. Penn Receives $10 Million to Create Center for Orphan Disease Research and Therapy10
. KRAS Diagnostic Test That Assists With Personalized Treatment of Colorectal Cancer Receives CE Mark11
. Arteriocyte Receives $1 Million Award From Ohio Third Frontier Program to Advance Its NANEX™ Technology Toward Clinical Use